1. Home
  2. RGEN vs KBR Comparison

RGEN vs KBR Comparison

Compare RGEN & KBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • KBR
  • Stock Information
  • Founded
  • RGEN 1981
  • KBR 1901
  • Country
  • RGEN United States
  • KBR United States
  • Employees
  • RGEN N/A
  • KBR N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • KBR Military/Government/Technical
  • Sector
  • RGEN Health Care
  • KBR Industrials
  • Exchange
  • RGEN Nasdaq
  • KBR Nasdaq
  • Market Cap
  • RGEN 8.2B
  • KBR 8.3B
  • IPO Year
  • RGEN N/A
  • KBR 2006
  • Fundamental
  • Price
  • RGEN $140.67
  • KBR $61.14
  • Analyst Decision
  • RGEN Buy
  • KBR Strong Buy
  • Analyst Count
  • RGEN 10
  • KBR 9
  • Target Price
  • RGEN $188.38
  • KBR $76.00
  • AVG Volume (30 Days)
  • RGEN 920.4K
  • KBR 767.1K
  • Earning Date
  • RGEN 10-29-2024
  • KBR 10-31-2024
  • Dividend Yield
  • RGEN N/A
  • KBR 0.98%
  • EPS Growth
  • RGEN N/A
  • KBR N/A
  • EPS
  • RGEN N/A
  • KBR 1.48
  • Revenue
  • RGEN $602,354,000.00
  • KBR $7,173,000,000.00
  • Revenue This Year
  • RGEN $0.08
  • KBR $9.66
  • Revenue Next Year
  • RGEN $12.97
  • KBR $13.63
  • P/E Ratio
  • RGEN N/A
  • KBR $41.25
  • Revenue Growth
  • RGEN N/A
  • KBR 7.22
  • 52 Week Low
  • RGEN $110.45
  • KBR $49.37
  • 52 Week High
  • RGEN $211.13
  • KBR $69.50
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 44.99
  • KBR 28.55
  • Support Level
  • RGEN $142.15
  • KBR $59.67
  • Resistance Level
  • RGEN $150.72
  • KBR $67.50
  • Average True Range (ATR)
  • RGEN 4.98
  • KBR 1.34
  • MACD
  • RGEN -0.86
  • KBR -0.84
  • Stochastic Oscillator
  • RGEN 31.90
  • KBR 10.89

About RGEN Repligen Corporation

Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America.

About KBR KBR Inc.

KBR (formerly Kellogg, Brown & Root) is global provider of technology, integrated engineering, procurement, and construction delivery, and operations and maintenance services. The company's business is organized into two segments: government solutions and sustainable technology solutions. KBR has operations in over 30 countries, and employs approximately 34,000 people. The firm generated $7 billion in revenue in 2023.

Share on Social Networks: